Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Loxapine
Therapeutic Area : Psychiatry/Psychology
Study Phase : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
IntelGenx Receives USPTO Notice of Allowance for Loxapine Orange Book Eligible Patent
Details : VersaFilm® (loxapine) is the first innovative oral thin film of loxapine for use in patients with agitation associated with schizophrenia and bipolar 1 disorder. utilizes IntelGenx’s proprietary VersaFilm® technology, allowing for an improved drug pr...
Product Name : VersaFilm
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
February 21, 2023
Lead Product(s) : Loxapine
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable